Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Pathology Oncology Research : POR|March 4, 2019
Syndecan-1 in Liver DiseasesEszter Regős, Katalin Karászi, Andrea Reszegi, et al.Scientific Reports|August 6, 2021
Alterations in protein expression and site-specific N-glycosylation of prostate cancer tissuesSimon Sugár, Gábor Tóth, Fanni Bugyi, et al.Pathology Oncology Research : POR|May 11, 2020
Aberrant Expression of Syndecan-1 in Cervical CancersKatalin Karászi, Renáta Vigh, Miklós Máthé, et al.Pathology Oncology Research : POR|October 30, 2017
The Presence of ALK Alterations and Clinical Relevance of Crizotinib Treatment in Pediatric Solid TumorsLuca Felkai, Rita Bánusz, Ilona Kovalszky, et al.BMC Cancer|April 18, 2015
Remodeling of extracellular matrix by normal and tumor-associated fibroblasts promotes cervical cancer progressionAlexandra Fullár, József Dudás, Lászlóné Oláh, et al.Biomolecules|August 23, 2020
The Protective Role of Decorin in Hepatic Metastasis of Colorectal CarcinomaAndrea Reszegi, Zsolt Horváth, Katalin Karászi, et al.Plos One|June 20, 2020
Two ways of epigenetic silencing of TFPI2 in cervical cancerAlexandra Fullár, Katalin Karászi, Péter Hollósi, et al.Biomolecules|September 26, 2020
Syndecan-1 Promotes Hepatocyte-Like Differentiation of Hepatoma Cells Targeting Ets-1 and AP-1Péter Hollósi, Lóránd Váncza, Katalin Karászi, et al.The Journal of Clinical Endocrinology and Metabolism|April 2, 2020
Demethylation Status of Somatic DNA Extracted From Pituitary Neuroendocrine Tumors Indicates Proliferative BehaviorBorbála Szabó, Kinga Németh, Katalin Mészáros, et al.Oncotarget|July 19, 2018
Survivin as a potential therapeutic target of acetylsalicylic acid in pituitary adenomasKinga Németh, Nikolette Szücs, Sándor Czirják, et al.Pageof 2